[go: up one dir, main page]

DE60023261D1 - Verfahren zur untersuchung der wechselwirkung von substanz und hormonrezeptor - Google Patents

Verfahren zur untersuchung der wechselwirkung von substanz und hormonrezeptor

Info

Publication number
DE60023261D1
DE60023261D1 DE60023261T DE60023261T DE60023261D1 DE 60023261 D1 DE60023261 D1 DE 60023261D1 DE 60023261 T DE60023261 T DE 60023261T DE 60023261 T DE60023261 T DE 60023261T DE 60023261 D1 DE60023261 D1 DE 60023261D1
Authority
DE
Germany
Prior art keywords
examining
interaction
substance
hormone receptor
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023261T
Other languages
English (en)
Other versions
DE60023261T2 (de
Inventor
Hiroko Sakamoto
Noriko Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olympus Corp
Original Assignee
Olympus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olympus Corp filed Critical Olympus Corp
Application granted granted Critical
Publication of DE60023261D1 publication Critical patent/DE60023261D1/de
Publication of DE60023261T2 publication Critical patent/DE60023261T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE60023261T 1999-07-23 2000-07-24 Verfahren zur untersuchung der wechselwirkung von substanz und hormonrezeptor Expired - Lifetime DE60023261T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP20986099 1999-07-23
JP20986099 1999-07-23
JP2000163475 2000-05-31
JP2000163476 2000-05-31
JP2000163475 2000-05-31
JP2000163476 2000-05-31
PCT/JP2000/004930 WO2001007919A1 (fr) 1999-07-23 2000-07-24 Procede visant a examiner une substance ayant une interaction avec un recepteur hormonal

Publications (2)

Publication Number Publication Date
DE60023261D1 true DE60023261D1 (de) 2006-03-02
DE60023261T2 DE60023261T2 (de) 2006-07-27

Family

ID=27329067

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023261T Expired - Lifetime DE60023261T2 (de) 1999-07-23 2000-07-24 Verfahren zur untersuchung der wechselwirkung von substanz und hormonrezeptor

Country Status (5)

Country Link
US (1) US20020072076A1 (de)
EP (1) EP1120653B1 (de)
JP (1) JP4406183B2 (de)
DE (1) DE60023261T2 (de)
WO (1) WO2001007919A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055984A2 (en) 2001-01-16 2002-07-18 Given Imaging Ltd. A system and method for determining in vivo body lumen conditions
JP2003177131A (ja) * 2001-12-11 2003-06-27 Olympus Optical Co Ltd 生物学的な結合親和性を検出する方法
AU2003211401A1 (en) * 2002-02-22 2003-09-09 Takeda Chemical Industries, Ltd. Method of determining ligand
EP1617221A4 (de) * 2003-04-23 2006-08-02 Olympus Corp Screening-verfahren für eine zur bindung an einen rezeptor fähige substanz
WO2004112567A2 (en) 2003-06-26 2004-12-29 Given Imaging Ltd. Methods, device and system for in vivo detection
US7460896B2 (en) 2003-07-29 2008-12-02 Given Imaging Ltd. In vivo device and method for collecting oximetry data
US20050142608A1 (en) * 2003-09-22 2005-06-30 Yokogawa Electric Corporation Screening method and device, and new drug screening method and device
JP4746276B2 (ja) * 2004-02-25 2011-08-10 オリンパス株式会社 膜構造を有する生体構造物の膜機能を解析する方法
GB0411198D0 (en) * 2004-05-20 2004-06-23 Gentronix Ltd Genotoxic testing
US8969008B2 (en) 2004-05-20 2015-03-03 Gentronix Limited Genotoxic testing
JP4509702B2 (ja) * 2004-08-31 2010-07-21 オリンパス株式会社 細胞内の顆粒状構造物の測定方法
WO2014022846A1 (en) * 2012-08-03 2014-02-06 Board Of Regents Of The University Of Nebraska Cancer biomarkers and methods of use thereof
DE102013202206B4 (de) 2013-02-11 2017-03-30 Technische Universität Dresden Methode zur Inhibierung des Proteins SWAP-70
AU2018361865B2 (en) * 2017-11-03 2024-01-18 Insitugen Limited Test kits and assays
US20240425910A1 (en) * 2021-11-05 2024-12-26 Cedars-Sinai Medical Center Kits and methods for quantitative assessment and enrichment of extrachromosomal circular dna
CN119757611B (zh) * 2025-03-06 2025-06-13 中国科学院昆明植物研究所 一种基于生物质谱与Tycho仪分析独脚金内酯类激素与受体蛋白互作的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264185A3 (de) * 1986-09-29 1989-05-31 Baylor College Of Medicine Harnstoffinduzierter DNS-Bindungstest zur quantitativen Bestimmung von Östrogenrezeptorproteinen
AU685054C (en) * 1992-05-14 2003-02-27 Baylor College Of Medicine Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
WO1994010338A1 (en) * 1992-10-30 1994-05-11 The General Hospital Corporation Nuclear hormone receptor-interacting polypeptides and related molecules and methods
WO1998055651A1 (en) * 1997-06-05 1998-12-10 University Of Massachusetts Method for determining rate of movement of a molecule in a living cell
US6733997B1 (en) * 1998-10-30 2004-05-11 National University Of Singapore Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins

Also Published As

Publication number Publication date
WO2001007919A1 (fr) 2001-02-01
EP1120653A1 (de) 2001-08-01
EP1120653A4 (de) 2003-05-21
JP4406183B2 (ja) 2010-01-27
DE60023261T2 (de) 2006-07-27
US20020072076A1 (en) 2002-06-13
EP1120653B1 (de) 2005-10-19

Similar Documents

Publication Publication Date Title
DE60023261D1 (de) Verfahren zur untersuchung der wechselwirkung von substanz und hormonrezeptor
DE10083668T1 (de) Knochenzementmischer und Verfahren
DE69826705D1 (de) Verfahren zur dermalen verabreichung von polypeptiden
DE60018907D1 (de) Verfahren und zusammensetzung zur zementierung von bohrlöchern
EP1028664A4 (de) Gerät und verfahren zur perkutanen myokardialvakularisation
EP1227821A4 (de) Therapeutische zusammensetzungen und verfahren zur verwendung davon
DE60039177D1 (de) Verfahren zur verbesserung der haut und des pelzes von haustieren
EE9800383A (et) Meetod bioloogiliselt sobivate biodegradeeruvate mikroosakeste valmistamiseks, mikroosakesed ja nendest koosnev materjal, farmatseutiline kompositsioon ning mikroosakeste kasutamine
DE69729236D1 (de) System und Verfahren zum Mischen von Knochenzement
DE69824312D1 (de) Verfahren und gerät zur beendigung von tachyarrhythmien
ATE253116T1 (de) Verbesserte antikörper gegen ige und verfahren zur verbesserung von antikörpern
DE69840301D1 (de) Verfahren und system zur ortsbestimmung von mobilfunkendgeräten
DE60010309D1 (de) Verfahren zur echtzeitdarstellung von medizinischen bildern
DE69528011D1 (de) Verfahren zur Pflege der Nägel
DE60044694D1 (de) Verfahren zur Bestimmung von Cholesterin und Sensor dafür
DE69924600D1 (de) Verfahren und gerät zur korrektion der röntgenstrahlbewegung
DE60043621D1 (de) Verbessertes transdermales verabreichungssystem zur empfängnisverhütung und verfahren
DE69918176D1 (de) Vorrichtung und verfahren zur erleichterung der verbindung von rohren
DE60037852D1 (de) Vorrichtung und Verfahren zur Kalibrierung der Auflösung von Röntgenbildern
DE69710231D1 (de) Verfahren und Einrichtung zur Bestimmung der Tabakfüllfähigkeitsqualität von Tabaksträngen
DE69834578D1 (de) Verfahren zur behandlung von zementaufschlämmungen
DE60037261D1 (de) Verfahren und gerät zur rekonstruktion von frank-brustableitungen
DE69836805D1 (de) Gerät und verfahren zur bilderzeugung
DE69733753D1 (de) Verfahren und Gerät zur Digitalwandlung von Winkeln
DE69706162D1 (de) Verfahren und gerät zur bestimmung der qualität von kulturpflanzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition